ADAR1 Capital Management »

Peregrine Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.5M 120k 12.35

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management